TdT Antikörper (AA 52-192)
Kurzübersicht für TdT Antikörper (AA 52-192) (ABIN7875554)
Target
Alle TdT (DNTT) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 52-192
-
Verwendungszweck
- TdT Antibody / DNA nucleotidylexotransferase
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A portion of amino acids 52-192 from the human protein was used as the immunogen for the TdT antibody.
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the TdT antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the TdT antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- TdT (DNTT) (Deoxynucleotidyltransferase, terminal (DNTT))
-
Andere Bezeichnung
- TdT
-
Hintergrund
- Terminal deoxynucleotidyltransferase (TdT) is a DNA polymerase which catalyzes the addition of deoxyribonucleotides onto the 3 termini of DNA. The human TdT gene maps to chromosome 10q24.1 and encodes a 510 amino acid protein. Human TdT is synthesized as a single chain peptide that elicits a minor preference for incorporation of deoxyribonucleotides over ribonucleotides forming DNA strands. It is present in immature thymocytes, some bone marrow cells, transformed pre-B and pre-T cell lines, and leukemia cells.
-
UniProt
- P04053
-
Pathways
- DNA Reparatur
Target
-